Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 405956, 8 pages
http://dx.doi.org/10.1155/2014/405956
Research Article

Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies

1Department of Immunology, Université Pierre et Marie Curie (AP-HP) Pitié-Salpêtrière Hospital, Paris, France
2Institute for Specialized Medicine, 4125 Sorrento Valley Blvd Suite A, Del Mar, San Diego, CA 92121, USA
3Inserm, U905 & Normandie University, IRIB, 76000 Rouen, France
4Department of Immunology, Rouen University Hospital, 76000 Rouen, France
5Department of Research, INOVA Diagnostics, INC., 9900 Old Grove Road, San Diego, CA 92131-1638, USA
6Departments of Neurology and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Received 22 November 2013; Accepted 10 January 2014; Published 5 March 2014

Academic Editor: Marvin J. Fritzler

Copyright © 2014 Lucile Musset et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Casciola-Rosen and A. L. Mammen, “Myositis autoantibodies,” Current Opinion in Rheumatology, vol. 24, pp. 602–608, 2012. View at Google Scholar
  2. A. Ghirardello, N. Bassi, L. Palma et al., “Autoantibodies in polymyositis and dermatomyositis,” Current Rheumatology Reports, vol. 15, article 335, 2013. View at Google Scholar
  3. I. N. Lazarou and P. A. Guerne, “Classification, diagnosis, and management of idiopathic inflammatory myopathies,” Journal of Rheumatology, vol. 40, pp. 550–564, 2013. View at Google Scholar
  4. A. Ghirardello, M. Rampudda, L. Ekholm et al., “Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay,” Rheumatology, vol. 49, no. 12, Article ID keq281, pp. 2370–2374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Christopher-Stine, L. A. Casciola-Rosen, G. Hong, T. Chung, A. M. Corse, and A. L. Mammen, “A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy,” Arthritis and Rheumatism, vol. 62, no. 9, pp. 2757–2766, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. L. Mammen, T. Chung, L. Christopher-Stine et al., “Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associated autoimmune myopathy,” Arthritis and Rheumatism, vol. 63, no. 3, pp. 713–721, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Allenbach and O. Benveniste, “Acquired necrotizing myopathies,” Current Opinion in Neurology, vol. 26, pp. 554–560, 2013. View at Google Scholar
  8. J. L. Werner, L. Christopher-Stine, S. R. Ghazarian et al., “Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy,” Arthritis and Rheumatism, vol. 64, pp. 4087–4093, 2012. View at Google Scholar
  9. P. Mohassel and A. L. Mammen, “The spectrum of statin myopathy,” Current Opinion in Rheumatology, vol. 25, pp. 747–752, 2013. View at Google Scholar
  10. P. Mohassel and A. L. Mammen, “Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies,” Muscle and Nerve, vol. 48, pp. 477–483, 2013. View at Google Scholar
  11. Y. Allenbach, L. Drouot, A. Rigolet et al., “Anti-HMGCR auto-antibodies in European patients with auto-immune necrotizing myopathies: inconstant exposure to statin,” Medicine. In press.
  12. M. Mahler, M. J. Fritzler, and M. Blüthner, “Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies,” Arthritis Research & Therapy, vol. 7, no. 1, pp. R19–R29, 2005. View at Google Scholar · View at Scopus
  13. C. Bentow, A. Swart, J. Wu et al., “Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens,” Clinica Chimica Acta, vol. 424, pp. 141–147, 2013. View at Google Scholar
  14. L. Drouot, Y. Allenbach, F. Jouen et al., “Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies,” Arthritis Research & Therapy, vol. 16, no. 1, article R39, 2014. View at Google Scholar
  15. M. Beyer, A. Nesterov, I. Block et al., “Combinatorial synthesis of peptide arrays onto a microchip,” Science, vol. 318, no. 5858, p. 1888, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Stadler, T. Felgenhauer, M. Beyer et al., “Combinatorial synthesis of peptide arrays with a laser printer,” Angewandte Chemie—International Edition, vol. 47, no. 37, pp. 7132–7135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Mammen, K. Pak, E. K. Williams et al., “Rarity of Anti-3-Hydroxy-3-Methylglutaryl-coenzyme a reductase antibodies in statin users, including those with self-limited musculoskeletal side effects,” Arthritis Care and Research, vol. 64, no. 2, pp. 269–272, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kein, H. Mann, J. Zamecnik, and J. Vencovsky, “Increasing incidence of immune mediated necrotizing myopathy in a single center,” in Proceedings of the Annual Congress of the American College of Rheumatology, 2013.
  19. M. Mahler and M. J. Fritzler, “Epitope specificity and significance in systemic autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1183, pp. 267–287, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Agmon-Levin, J. Damoiseaux, C. Kallenberg et al., “International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies,” Annals of Rheumatic Diseases, vol. 73, no. 1, pp. 17–23, 2014. View at Google Scholar